Literature DB >> 21453754

Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus: co-localization with tryptophan hydroxylase.

J L Lukkes1, D R Staub, A Dietrich, W Truitt, A Neufeld-Cohen, A Chen, P L Johnson, A Shekhar, C A Lowry.   

Abstract

Corticotropin-releasing factor (CRF) and CRF-related neuropeptides are involved in the regulation of stress-related physiology and behavior. Members of the CRF family of neuropeptides bind to two known receptors, the CRF type 1 (CRF₁) receptor, and the CRF type 2 (CRF₂) receptor. Although the distribution of CRF₂ receptor mRNA expression has been extensively studied, the distribution of CRF₂ receptor protein has not been characterized. An area of the brain known to contain high levels of CRF₂ receptor mRNA expression and CRF₂ receptor binding is the dorsal raphe nucleus (DR). In the present study we investigated in detail the distribution of CRF₂ receptor immunoreactivity throughout the rostrocaudal extent of the DR. CRF₂ receptor-immunoreactive perikarya were observed throughout the DR, with the highest number and density in the mid-rostrocaudal DR. Dual immunofluorescence revealed that CRF₂ receptor immunoreactivity was frequently co-localized with tryptophan hydroxylase, a marker of serotonergic neurons. This study provides evidence that CRF₂ receptor protein is expressed in the DR, and that CRF₂ receptors are expressed in topographically organized subpopulations of cells in the DR, including serotonergic neurons. Furthermore, these data are consistent with the hypothesis that CRF₂ receptors play an important role in the regulation of stress-related physiology and behavior through actions on serotonergic and non-serotonergic neurons within the DR.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453754      PMCID: PMC3092641          DOI: 10.1016/j.neuroscience.2011.03.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  86 in total

1.  Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens.

Authors:  Jodi L Lukkes; Gina L Forster; Kenneth J Renner; Cliff H Summers
Journal:  Eur J Pharmacol       Date:  2007-10-02       Impact factor: 4.432

2.  Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits.

Authors:  A Neufeld-Cohen; A K Evans; D Getselter; A Spyroglou; A Hill; S Gil; M Tsoory; F Beuschlein; C A Lowry; W Vale; A Chen
Journal:  Mol Psychiatry       Date:  2009-11-03       Impact factor: 15.992

3.  Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide.

Authors:  Helene Bach-Mizrachi; Mark D Underwood; Suham A Kassir; Mihran J Bakalian; Etienne Sibille; Hadassah Tamir; J John Mann; Victoria Arango
Journal:  Neuropsychopharmacology       Date:  2006-04       Impact factor: 7.853

4.  Increased tryptophan hydroxylase immunoreactivity in the dorsal raphe nucleus of alcohol-dependent, depressed suicide subjects is restricted to the dorsal subnucleus.

Authors:  Willy L Bonkale; Gustavo Turecki; Mark C Austin
Journal:  Synapse       Date:  2006-07       Impact factor: 2.562

5.  Simultaneous analysis of serotonin transporter, tryptophan hydroxylase 1 and 2 gene expression in the ventral prefrontal cortex of suicide victims.

Authors:  Nader Perroud; Elizabeth Neidhart; Brice Petit; Monique Vessaz; Térèse Laforge; Céline Relecom; Romano La Harpe; Alain Malafosse; Michel Guipponi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

6.  Urocortin modulates inflammatory response and neurotoxicity induced by microglial activation.

Authors:  Mei-Jen Wang; Shinn-Zong Lin; Jon-Son Kuo; Hsin-Yi Huang; Shih-Fang Tzeng; Chia-Hsin Liao; Der-Cherng Chen; Wu-Fu Chen
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

7.  Early life social isolation alters corticotropin-releasing factor responses in adult rats.

Authors:  J L Lukkes; C H Summers; J L Scholl; K J Renner; G L Forster
Journal:  Neuroscience       Date:  2008-10-30       Impact factor: 3.590

8.  Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus.

Authors:  Maria Waselus; Cristiano Nazzaro; Rita J Valentino; Elisabeth J Van Bockstaele
Journal:  Biol Psychiatry       Date:  2009-04-11       Impact factor: 13.382

9.  Elevated expression of tryptophan hydroxylase-2 mRNA at the neuronal level in the dorsal and median raphe nuclei of depressed suicides.

Authors:  H Bach-Mizrachi; M D Underwood; A Tin; S P Ellis; J J Mann; V Arango
Journal:  Mol Psychiatry       Date:  2008-01-08       Impact factor: 15.992

10.  Soluble corticotropin-releasing hormone receptor 2alpha splice variant is efficiently translated but not trafficked for secretion.

Authors:  Ryan T Evans; Audrey F Seasholtz
Journal:  Endocrinology       Date:  2009-06-11       Impact factor: 4.736

View more
  18 in total

Review 1.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

Review 2.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

Review 3.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

4.  Crh receptor priming in the bed nucleus of the stria terminalis (BNST) induces tph2 gene expression in the dorsomedial dorsal raphe nucleus and chronic anxiety.

Authors:  Nina C Donner; Sofia M Davies; Stephanie D Fitz; Drake M Kienzle; Anantha Shekhar; Christopher A Lowry
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-08-12       Impact factor: 5.067

5.  Age-related changes in central effects of corticotropin-releasing factor (CRF) suggest a role for this mediator in aging anorexia and cachexia.

Authors:  Judit Tenk; Ildikó Rostás; Nóra Füredi; Alexandra Mikó; Margit Solymár; Szilvia Soós; Balázs Gaszner; Diana Feller; Miklós Székely; Erika Pétervári; Márta Balaskó
Journal:  Geroscience       Date:  2017-01-18       Impact factor: 7.713

6.  Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram.

Authors:  Inbar Zohar; Liat Dosoretz-Abittan; Shai Shoham; Marta Weinstock
Journal:  Psychopharmacology (Berl)       Date:  2014-11-26       Impact factor: 4.530

7.  Chronic-Stress-Induced Behavioral Changes Associated with Subregion-Selective Serotonin Cell Death in the Dorsal Raphe.

Authors:  Reka Natarajan; Laura Forrester; Nicolas L Chiaia; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2017-05-25       Impact factor: 6.167

Review 8.  Sex differences in anxiety and emotional behavior.

Authors:  Nina C Donner; Christopher A Lowry
Journal:  Pflugers Arch       Date:  2013-04-16       Impact factor: 3.657

9.  Serotonergic systems in the balance: CRHR1 and CRHR2 differentially control stress-induced serotonin synthesis.

Authors:  Nina C Donner; Philip H Siebler; Danté T Johnson; Marcos D Villarreal; Sofia Mani; Allison J Matti; Christopher A Lowry
Journal:  Psychoneuroendocrinology       Date:  2015-09-30       Impact factor: 4.905

10.  Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells.

Authors:  J Fuenzalida; P Galaz; K A Araya; P G Slater; E H Blanco; J M Campusano; F Ciruela; K Gysling
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.